SCHEMBL7330812

SCHEMBL7330812

CCOC(=O)CN(C(=O)[C@H](CC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)C1CCC1

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
HTT P42858 1/20 0.45
CACNA1B Q00975 5/20 0.40
CYP2D6 P10635 1/20 0.38
CTSK P43235 3/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
F7 P08709 1/20 0.37
CTSS P25774 2/20 0.36
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
CTSL P07711 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7332029 0.99 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19HTTCACNA1B
SCHEMBL7398204 0.98 CYP1A2 (0.43) CYP1A2CYP2C9CYP2C19HTTCACNA1B
SCHEMBL7572754 0.97 CYP1A2 (0.46) CYP1A2CYP2C9CYP2C19HTTCACNA1B
SCHEMBL8719543 0.92 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19HTTCACNA1B
SCHEMBL8721817 0.91 CYP1A2 (0.43) CYP1A2CYP2C9CYP2C19HTTCACNA1B
SCHEMBL7296673 0.86 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19HTTCACNA1B
SCHEMBL7395604 0.84 KMT2A (0.39) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL7393473 0.82 SYK (0.46) CACNA1BCTSKCTSSCTSL
SCHEMBL7394796 0.82 KMT2A (0.40) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL7394187 0.82 CYP1A2 (0.49) CYP1A2CYP2C9CYP2C19HTTCACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0559046-B1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors HOFFMANN LA ROCHE (CH) 2001-07-11 EP disclosed
EP-0559046-A1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1993-09-08 EP disclosed